HOME BANCSHARES Reports Record Annual Income and EPS, Driven by Strong Q4 Loan Growth and Sub-40% Efficiency Ratio
summarizeSummary
Home BancShares reported record annual net income and diluted EPS for 2025, fueled by robust fourth-quarter performance including significant loan growth, an improved efficiency ratio, and strong asset quality. The company also increased its quarterly dividend.
check_boxKey Events
-
Record Annual Net Income and EPS
Achieved record annual net income of $475.4 million and diluted EPS of $2.41 for 2025, representing an 18% and 20% year-over-year increase, respectively.
-
Strong Q4 Loan Growth
Reported $400.2 million in loan growth during Q4 2025, bringing total loans to a record $15.69 billion.
-
Improved Operational Efficiency
Achieved a sub-40% efficiency ratio of 39.54% in Q4 2025, indicating effective cost management.
-
Enhanced Shareholder Returns
Increased quarterly dividend by 5% to $0.21 per share and repurchased 540,706 shares of common stock in Q4 2025.
auto_awesomeAnalysis
Home BancShares delivered exceptional financial results for the fourth quarter and full year 2025, demonstrating strong operational execution and profitability. The company achieved record annual net income of $475.4 million and diluted earnings per share of $2.41, representing an 18% and 20% year-over-year increase, respectively. Key drivers included substantial loan growth of $400.2 million in Q4, pushing total loans to a record $15.69 billion, and a highly efficient operating model reflected by a sub-40% efficiency ratio (39.54%). The net interest margin also expanded to 4.61%, and return on average assets improved to 2.06%. Furthermore, asset quality remained strong with non-performing assets to total assets decreasing to 0.55%, and the company increased its quarterly dividend by 5%. These results, coupled with a record book value per share, indicate robust financial health and a strong outlook for the company.
At the time of this filing, HOMB was trading at $28.00 on NYSE in the Finance sector, with a market capitalization of approximately $5.6B. The 52-week trading range was $24.22 to $31.27. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.